These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 25752488)
1. Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1). Pechalrieu D; Lopez M Expert Opin Ther Pat; 2015 Jun; 25(6):729-35. PubMed ID: 25752488 [TBL] [Abstract][Full Text] [Related]
2. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Isolation, identification and drug sensitivity pattern of mycobacterial strains isolated from human patients. Nain PS; Chandiramani NK; Darg DN Indian J Pathol Microbiol; 1987 Jul; 30(3):261-6. PubMed ID: 3130312 [No Abstract] [Full Text] [Related]
5. Sawicki R; Ginalska G Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522 [TBL] [Abstract][Full Text] [Related]
6. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]